- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 16, 2025 | 754.01M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $53.39B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $53.63B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $7.93B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.28B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $13.53B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $12.48B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$3.33B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$3.91B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $103.65B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $97.08B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $159.82B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $160.28B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $127.66B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $128B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $156.49B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $156.36B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $13.8B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $6.91B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 612.9M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $567M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.36B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.16B |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $868M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$343M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$86M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.88B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $14.69B |